Award
National Cancer Institute PA-23-260
Novel Approach to Hepatocellular Carcinoma Treatment through Enhanced ER Stress
Recipient
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
Award Amount
$39,646.00
Ceiling
$39,646.00
Awarded
February 05, 2026
Identifier
PA-23-260
NIH grant awarded to University of Texas Health Science Center for research on novel hepatocellular carcinoma treatment via enhanced ER stress, with a project duration from 2025 to 2030 and an award amount of $39,646.
Description
This is a NIH grant opportunity for research on hepatocellular carcinoma (HCC) focusing on ER stress and novel therapeutics. The project involves in vivo and in vitro studies, molecular biology, proteomics, transcriptomics, and preclinical models. The project aims to develop new strategies for HCC treatment using ERX-315 targeting LIPA.